Human Btnl3 Proteins, Nucleic Acids, And Antibodies And Uses Thereof
Patent No. EP2875046 (titled "Human Btnl3 Proteins, Nucleic Acids, And Antibodies And Uses Thereof") was filed by Amgen on Jul 18, 2013. The application was issued on Apr 30, 2025.
Patent Summary
Patent Family
Patent Oppositions
Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.
Dossier Documents
The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.
Get instant alerts for new documents
EP2875046
- Filing Date
- Jul 18, 2013
- Status
- Granted
- Publication Date
- Apr 30, 2025
- External Links
- Slate, Register , Google Patents